This inventor holds 1 USPTO granted patent. Top assignee: Amersham International Plc. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984
Title: Roy Abrahams: Innovator in Radiopharmaceuticals
Introduction
Roy Abrahams is a notable inventor based in Amersham, GB. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods and compositions. His work has implications for medical imaging and treatment, showcasing the importance of advancements in this area.
Latest Patents
Roy Abrahams holds a patent for a method and reagent for making a radiopharmaceutical composition. This patent describes a method of creating a radiopharmaceutical composition by mixing an aqueous solution of pertechnetate with a reducing agent, which can be either tin metal or stannous ion. This process reduces the pertechnetate and incorporates a complexing agent to form a complex with the reduced technetium. A key feature of this invention is the incorporation of nitrate and/or nitrite to diminish the oxidation of Sn²⁺ to Sn⁴⁺, preventing the re-oxidation of technetium to pertechnetate during preparation and storage. The use of nitrate and nitrite is highlighted as superior to previously proposed organic antioxidants. The reagent for this purpose typically comprises the reducing agent, the complexing agent, and the nitrate and/or nitrite in a sterile freeze-dried state.
Career Highlights
Roy Abrahams has been associated with Amersham International Plc, where he has applied his expertise in the development of radiopharmaceuticals. His work has contributed to advancements in medical imaging technologies, enhancing the capabilities of healthcare professionals in diagnosing and treating various conditions.
Collaborations
Throughout his career, Roy has collaborated with notable colleagues, including Anthony Brockas and James D Kelly. These collaborations have likely fostered an environment of innovation and shared knowledge, further advancing the field of radiopharmaceuticals.
Conclusion
Roy Abrahams is a distinguished inventor whose work in radiopharmaceuticals has made a significant impact on medical science. His innovative methods and compositions continue to influence the development of effective diagnostic and therapeutic tools.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile